Biotinylated RNA |
mRNA |
In vitro
|
Strong combination between streptavidin beads and biotinylated RNA |
Potentially biased toward abundant proteins |
Zheng et al. (2016)
|
S1 aptamer |
mRNA |
In vitro
|
Simple purification without the need for recombinant protein production |
Potentially biased toward abundant proteins; interference with native RBPs formation; unspecific interactions |
Leppek and Stoecklin (2014)
|
RAP |
lncRNA |
In vivo
|
Strong combination between probe and RNA |
High input cell numbers |
McHugh et al. (2015)
|
TRIP |
mRNA |
In vivo
|
No need of genetic manipulation; UV cross-linking |
Careful design and evaluation of ASO; differences in ASO binding sites may reduce efficiency |
Matia-González et al. (2017)
|
PAIR |
mRNA |
In vivo
|
UV cross-linking |
Difficult to product peptide nucleic acid |
Zeng et al. (2006)
|
CHART |
lncRNA |
In vivo
|
Simple design; split pools of tiling oligonucleotide probes and glutaraldehyde crosslinking ensure the success |
High input cell numbers |
Chu et al. (2011)
|
RaPID |
mRNA |
In vivo
|
Low number of cells needed; interrogate motifs <50 nucleotides |
Requires BoxB link to RNA; not all proteins can be detected due to biotinylation; it’s difficult to tell whether the protein is acting directly or indirectly |
Ramanathan et al. (2018)
|
CARPID |
lncRNA |
In vivo
|
No need of genetic manipulation; Multiple gRNAs are designed to reduce background noise |
Need a high abundance of targeted RNA; unstable binding; difficult to detect all the proteins due to the limitation of gRNA |
Yi et al. (2020)
|
Cas13-based APEX targeting |
hTR |
In vivo
|
No need of genetic manipulation; introduce double-stranded RNA binding domain (dsRBD) to improve the stability of dCas13 complex |
Need a high abundance of targeted RNA; unstable binding; difficult to detect all the proteins due to the limitation of gRNA |
Han et al. (2020)
|
CRUIS |
lncRNA, mRNA |
In vivo
|
No need of genetic manipulation; no restriction on the type of RNA |
Need a high abundance of targeted RNA; unstable binding; difficult to detect all the proteins due to the limitation of gRNA |
Zhang et al. (2020)
|
CBRPP |
lncRNA, mRNA |
In vivo
|
No need of genetic manipulation; no restriction on the type of RNA |
Need a high abundance of targeted RNA; unstable binding; difficult to detect all the proteins due to the limitation of gRNA |
Li et al. (2021)
|
RPL |
snRNA |
In vivo
|
No need of genetic manipulation; no restriction on the type of RNA |
Need a high abundance of targeted RNA; unstable binding; difficult to detect all the proteins due to the limitation of gRNA |
Lin et al. (2021)
|
CBRIP |
snRNA |
In vivo
|
No restriction on the type of RNA; high stability and specificity |
Need a high abundance of targeted RNA; difficult to detect all the proteins because of the limitation of gRNA |
Chen et al. (2021)
|